Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

MARKET VECTORS BIOTECH ETF: (BBH)

(Delayed quote from AMEX) As of Aug 29, 2014 03:59 PM ET

 Add to portfolio

$107.06 USD

+1.07 (1.01%)

Volume: 56,103

Zacks ETF Rank: 3 - Hold [?]     3    

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 105.99
Open 106.38
Bid 104.89
Ask 109.05
Day Low-High 106.10-107.21
52wk Low-High 74.27-107.21
Volume 56,103
NAV (month end) 96.85
Premium (+)/Discount (-) (month end)+9.14

Zacks Premium Research for BBH

Zacks ETF Rank [?] Hold 3
ETF Risk [?] Med
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $0.00 (0.00%)
Issuer VAN ECK

Benchmark for BBH

MARKET VECTORS US LISTED BIOTECH 25 INDE

This benchmark index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

Fund Summary for BBH

MARKET VECTORS BIOTECH ETF

The Market Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is a rules based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.